Nada A. Hindiyeh
Neurology
2261 Market St
San Francisco, CA 94114
San Francisco, CA 94114
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Shift from chronic to episodic migraine frequency in a long-term phase 3 study of galcanezumab.
Journal: The journal of headache and pain
Published: July 25, 2024
Changes in Use of Migraine Medications, Healthcare Resource Utilization, and Associated Direct Costs Over 12 Months Following Initiation of Erenumab: A US Retrospective Real-World Analysis.
Journal: Pain and therapy
Published: June 04, 2024
Long-Term Epidural Patching Outcomes and Predictors of Benefit in Patients With Suspected CSF Leak Nonconforming to ICHD-3 Criteria.
Journal: Neurology
Published: May 31, 2024
The Gut-brain Connection and Episodic Migraine: an Update.
Journal: Current pain and headache reports
Published: September 15, 2023
Using artificial intelligence to identify patients with migraine and associated symptoms and conditions within electronic health records.
Journal: BMC medical informatics and decision making
Published: August 12, 2022
Development and validation of a novel model for characterizing migraine outcomes within real-world data.
Journal: The journal of headache and pain
Published: July 25, 2022
Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial.
Journal: Cephalalgia : an international journal of headache
Published: January 10, 2022
Can we anticipate how Ramadan fasting will affect migraine?
Journal: Headache
Published: September 08, 2021
Hemicrania continua: Indomethacin induced myoclonus.
Journal: Clinical neurology and neurosurgery
Published: January 23, 2021
Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine.
Journal: The journal of headache and pain
Published: December 28, 2020
A link between gastrointestinal disorders and migraine: Insights into the gut-brain connection.
Journal: Headache
Published: October 06, 2020
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study.
Journal: The journal of headache and pain
Published: July 17, 2020
Last Updated: 09/26/2026